
Published by Biohacking Elite · Published November 14, 2026. No specialist review is claimed.
In brief: A peptide certificate of analysis can report an endotoxin result and an elemental-impurity result only for the sample that was tested, under the method, units, and limit written on that report. Endotoxin testing — the bacterial endotoxins test (BET), including Limulus amoebocyte lysate (LAL) methods and recombinant Factor C or recombinant cascade methods — detects or quantifies endotoxins associated with Gram-negative bacteria. Elemental-impurity testing, often labeled “heavy metals,” determines specified elements, such as lead, arsenic, cadmium, and mercury, against a stated limit. Neither result establishes identity, chromatographic purity, sterility, or suitability for human or animal use. This Biohacking Elite guide reviews research-material documentation only.
What endotoxin testing measures
Bacterial endotoxins are associated with Gram-negative bacteria. The test detects or quantifies those endotoxins in a prepared sample. It is not a test for every microbial toxin or for viable microorganisms. A sterility or bioburden result answers a different question; see peptide sterility testing: what a COA result can establish.
The United States Pharmacopeia describes the Bacterial Endotoxins Test in general chapter <85> as a test to detect or quantify endotoxins from Gram-negative bacteria using amoebocyte lysate from the horseshoe crab. That method is commonly called an LAL test. FDA’s March 2026 guidance, Pyrogen and Endotoxins Testing: Questions and Answers (Edition 2), discusses the recommendations and acceptance criteria in USP chapter <85> and describes the gel-clot, photometric, and kinetic test methods. Those documents are cited here as method context, not as a claim that every research material is a drug product.
USP general chapter <86>, Bacterial Endotoxins Test Using Recombinant Reagents, provides techniques that use non-animal-derived reagents, including recombinant Factor C (rFC) and recombinant cascade (rCR) methods. USP’s public page for the Endotoxin Reference Standard summarizes both chapters. In a March 2026 update, FDA said Edition 2 removed certain LAL-only references to accommodate recombinant reagents and that method suitability should be verified. A COA that only says “endotoxin: pass,” without naming the technique, leaves that step unshown.
Results are typically expressed in Endotoxin Units (EU), sometimes with a denominator such as EU per milliliter or EU per milligram. The number is meaningful only beside the method, the stated limit, and the units. A less-than detection or quantitation limit is not the same as “zero,” and a result for one prepared sample is not a measurement of every container in a lot.
What heavy-metal and elemental-impurity testing measures
On research-material certificates, “heavy metals” usually means a panel of elemental impurities. In the United States Pharmacopeia, general chapters <232> Elemental Impurities—Limits and <233> Elemental Impurities—Procedures replaced the older general chapter <231> Heavy Metals. FDA’s August 2018 guidance, Elemental Impurities in Drug Products, states that <232> sets limits for elemental impurities in finished drug products, and that <233> describes the analytical procedures ordinarily used to determine those amounts, plus criteria for acceptable procedures. See the official USP-NF listings for <232> and <233> for the current official text.
ICH Q3D(R2), Guideline for Elemental Impurities, addresses elemental impurities in drug products. FDA has a corresponding Q3D(R2) guidance page. In Q3D(R2), Class 1 elements are arsenic (As), cadmium (Cd), mercury (Hg), and lead (Pb). Those four names appear frequently on peptide certificates; other elements may also be reported. A research-material COA that cites USP <232>, USP <233>, or ICH Q3D is documenting a measured result against a stated specification. That citation does not convert the material into a drug product or establish suitability for any use.
Inductively coupled plasma mass spectrometry (ICP-MS) is an instrumental technique used to determine many elements at low concentrations: a prepared sample is introduced into a high-temperature plasma, and the resulting ions are measured by their mass-to-charge ratios. Other instrumental procedures may be used. ICH Q3D(R2) states that determinations should use procedures suitable for their intended purposes, including pharmacopoeial or suitable alternative procedures. FDA recommends the procedures in USP <233> or, if those cannot be used, procedures that meet that chapter’s validation requirements. A certificate should name the actual procedure used.
What to look for on a COA
Read each endotoxin and elemental-impurity line as a set of fields, not as a marketing claim. For a field-by-field walkthrough, start with the certificate-of-analysis guide for research compounds and confirm the report with the laboratory using peptide COA verification.
- Method. Name the procedure actually used — for example, a gel-clot, photometric, or kinetic BET; an rFC or rCR method; or an instrumental elemental method such as ICP-MS. A chapter number without a method description is incomplete.
- Limit or specification. A stated acceptance criterion, in stated units. “Within specification” is not reviewable if the specification is missing.
- Result. Prefer a numeric result, or a clearly stated less-than value at a named detection or quantitation limit, over a bare “pass.”
- Units. The result and the limit must use the same unit basis. EU per milligram is not interchangeable with EU per vial or EU per milliliter unless the report shows the conversion. Micrograms per gram and parts per million likewise need a stated relationship.
- Laboratory identification and accreditation. The issuing laboratory should be named so the report can be checked. Some laboratories also state accreditation such as ISO/IEC 17025. If that is claimed, record the laboratory name, the accreditation body, and any scope identifier. Accreditation is not itself a passing result for the lot, and a logo without a verifiable laboratory name is not enough.
- Lot match. Confirm that the tested sample is documented as belonging to the supplier lot on hand. A laboratory sample number may differ from a supplier lot number; the relationship should be recorded. The laboratory verification directory describes how to check a report through the issuing laboratory’s official channel.
What a COA cannot show
A verified endotoxin or elemental-impurity line still has a limited scope. It describes the tested sample, at the stage represented by that sample, under the stated method. It does not automatically describe every vial in the lot, material after later handling, or a different lot. It does not establish peptide identity or chromatographic purity; those are separate measurements, discussed in how HPLC purity is measured. It also does not establish sterility, manufacturing history, or storage after the test date.
FDA explains, in a pharmaceutical current good manufacturing practice context, why testing alone does not assure quality and why process controls matter. That is context for not treating a single passing attachment as a complete quality system, not a claim that every pharmaceutical requirement applies to every research material. A test-scope table is in third-party tested peptides.
Red flags
- A “pass” or “meets USP” line with no method, no numeric result or detection limit, no units, and no stated specification.
- A result and a limit expressed in different units, with no conversion shown.
- A supplier lot number that does not match the tested sample, or no explanation of how the two identifiers are related.
- An endotoxin result presented as proof of sterility, or an HPLC purity figure presented as a heavy-metal or elemental-impurity result.
- A single “heavy metals” total with no named elements, especially if the report cites USP <232> or ICH Q3D, which address specified elements.
- A cropped, incomplete, or unverifiable PDF, or an accreditation mark with no laboratory name that can be checked independently.
- A chapter or guideline cited as if it were a result, without evidence that the named procedure was applied to the sample.
Review table
| COA field | Question it can address | It cannot, by itself, establish |
|---|---|---|
| Endotoxin method, result, units, and limit | What endotoxin result was measured in the tested sample under the stated method? | Sterility, identity, or the condition of untested containers |
| Elemental-impurity method, result, units, and limit | What amount of each named element was reported against the stated specification? | A complete impurity profile, HPLC purity, or suitability for any use |
| Laboratory name and any accreditation statement | Which laboratory issued the report, and what accreditation, if any, is claimed? | That this lot passed a test, or that the accreditation scope covers the method used |
| Supplier lot and laboratory sample identifiers | Is the tested sample documented as belonging to the lot on hand? | The condition of a different lot or of material after later handling |
Related documentation guides
Peptide sterility testing: what a COA result can establish; how to verify a peptide COA: Janoshik, Vanguard and MZ Biolabs; peptide COA verification: check the report with the lab; third-party tested peptides — test-scope evidence table; understanding certificates of analysis for research compounds.
Sources
- FDA, Pyrogen and Endotoxins Testing: Questions and Answers (Edition 2, March 2026) (PDF)
- FDA clarification on recombinant reagents and USP <86> (March 2026)
- USP Endotoxin Reference Standard page (chapters <85> and <86>)
- USP-NF listings (public previews): <85>, <232>, <233>
- FDA, Elemental Impurities in Drug Products (August 2018) (PDF)
- FDA Q3D(R2) guidance page and the ICH Q3D(R2) guideline PDF
- FDA facts on current good manufacturing practice
Chapter listings are references to official titles, not substitutes for the current official text.
Research use only: Research materials discussed here are for qualified laboratory research only, not for human or veterinary use. This article concerns documentation and analytical review, not personal-use instructions.
About this resource
Biohacking Elite — editorial resource for laboratory research and documentation literacy. No specialist review is claimed. This resource is not a laboratory report, accreditation endorsement, legal advice, or a substitute for lot-specific evidence.

